Cortisone treatment of chronic obstructive pulmonary disease: Contra;Kortisontherapie bei der chronisch-obstruktiven Bronchitis

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 8, 2000, Pages 222-223

  Gillissen, Adrian ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; LUNG FUNCTION TEST; PRACTICE GUIDELINE; SHORT SURVEY;

EID: 0034712177     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024055     Document Type: Short Survey

References (27)

1. 1 American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152 (1995), S77-S120.
2. 2 Anthonisen, N. R., J. E. Connett, J. P. Kiley et al.: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. JAMA 272 (1994), 1539-1541.
3. 3 Barnes, P. J.: New therapies for chronic obstructive pulmonary disease. Thorax 53 (1998), 137-147.
4. 4 British Thoracic Society: Guidelines for the management of chronic obstructive pulmonary disease. Thorax 52 (1997), S1 -S28.
5. 5 Burge, P. S.: EUROSCOP, ISOLDE and the Copenhagen City Lung Study. Thorax 54 (1999), 287-288.
6. 6 Calverley, P. M. A.: Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease. Thorax 54 (1999), 3-4.
7. 7 Chanez, P. et al.: Corticosteroid reversibility in COPD is related to features of asthma. Am. J. Respir. Crit. Care Med. 155 (1997), 1529-1534.
8. 8 Deutsche Atemwegsliga: Vorschläge zur Diagnostik und Therapie des chronischen Cor Pulmonale. Pneumologie 48 (1994), 287-291.
9. 9 Fabbri, L. M., G. Caramori, B. Beghe et al.: Chronic obstructive pulmonary disease international guidelines. Curr. Opin. Pulm. Med. 4 (1998), 76.
10. 10 Fletcher, C., R. Peto: The natural history of chronic airway obstruction. Br. Med. J. 1 (1977), 1645-1648.
11. 11 Fujimoto, K., K. Kubo, H. Yamamoto et al.: Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 115 (1999), 697-702.
12. 12 Gillissen, A., E. W. Schmidt: Die chronische Bronchitis und ihre Folgen. Versicherungsmedizin 6 (1996), 200-207.
13. 13 Grunsven van, P. M. et al.: Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease. Thorax 54 (1999), 7-14.
14. 14 Jeffery, P. K.: Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53 (1998), 129-136.
15. 15 Keatings, V. M., A. Jatakanon, Y. M. Worsdell, P. J. Barnes: Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155 (1997), 542-548.
16. 16 Leuenberger, P., H. P. Anderhub, O. Brändli et al.: Management 1997 of chronic obstructive pulmonary disease. Schweiz. Med. Wochenschr. 127 (1997), 766-782.
17. 17 McEvoy, C. E., D. E. Niewoehner: Adverse effects of corticosteroid therapy for COPD. A critical review. Chest 111 (1997), 732-743.
18. 18 Nishimura, K., et al.: The effect of high-dose inhaled beclomethasone dipropionate in patients with stable COPD. Chest 115 (1999), 31-37.
19. 19 O'Byrne, P. M., D. S. Postma: The many faces of airway inflammation. Am. J. Respir. Crit. Care Med. 159 (1999), S41-S66.
20. 20 Pauwels, R. A., C.-G. Lofdahl et al.: Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N. Engl. J. Med. 340 (1999), 1948-1953.
21. 21 Renkema, T. E. J., J. P. Schouten, G. H. Koeter, D. S. Postma: Effects of long-term treatment with corticosteroids in COPD. Chest 109 (1996), 1156.
22. 22 Schayck, C. P. et al.: Do patients with COPD benefit from treatment with inhaled corticosteroids. Eur. Respir. J. 9 (1996), 1969-1972.
23. 23 Shim, C. S., M. H. Williams: Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. Am. J. Med. 78 (1985), 655-658.
24. 24 Siafakas, N. M. et al.: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir.J. 8 (1995), 1398.
25. 25 Thompson, W. H., C. P. Nielson, P. Carvalho, N. B. Charan, J. J. Crowley: Controlled trial of oral prednisolone in outpatients with acute COPD exacerbations. Am. J. Respir. Crit. Care Med. 154 ( 1996), 407-412.
26. 26 Vestbo, J., T. Sørensen, P. Langer, A. Brix, P. Torre, K. Viskum: Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease. Lancet 355 (1999), 1819-1823.
27. 27 Wedzicha, J. A.: Inhaled corticosteroids in COPD: awaiting controlled trials. Thorax 48 (1993), 305-307.